Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Immunology

Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 Last 

Illinois

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Texas

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Czech Republic

Brno

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Prague

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Praha Prague

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Praha 10 Vinohrady

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Usti nad Labem

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

France

Bordeaux

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Lille

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Lyon

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Toulouse

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Germany

Aachen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Düsseldorf

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Heidelberg

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Tübingen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Italy

Milano

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Pisa

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Japan

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Sendai-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

View More ▼

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Malaysia

Ampang Selangor

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Kuala Lumpur

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Penang

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Netherlands

Amsterdam

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Nieuwegein

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Nijmegen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Poland

Gdansk

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Krakow

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Warszawa

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Russian Federation

Moscow

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Moscow

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

St. Petersburg

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Spain

A Coruña

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Alcalá de Henares

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Alcorcón

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Barcelona

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Barcelona

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

View More ▼

Barcelona

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Barcelona

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Cádiz

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Madrid

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Madrid

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Oviedo

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Pamplona

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Thailand

Bangkok

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

First 1 2 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.